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Abstract
Nitration of pollen derived allergens can occur by NO2 and ozone in polluted air and it has already been shown that nitrated
major birch (Betula verrucosa) pollen allergen Bet v 1.0101 (Bet v 1) exhibits an increased potency to trigger an immune
response. However, the mechanisms by which nitration might contribute to the induction of allergy are still unknown. In
this study, we assessed the effect of chemically induced nitration of Bet v 1 on the generation of HLA-DR associated
peptides. Human dendritic cells were loaded with unmodified Bet v 1 or nitrated Bet v 1, and the naturally processed HLA-
DR associated peptides were subsequently identified by liquid chromatography-mass spectrometry. Nitration of Bet v 1
resulted in enhanced presentation of allergen-derived HLA-DR-associated peptides. Both the copy number of Bet v 1
derived peptides as well as the number of nested clusters was increased. Our study shows that nitration of Bet v 1 alters
antigen processing and presentation via HLA-DR, by enhancing both the quality and the quantity of the Bet v 1-specific
peptide repertoire. These findings indicate that air pollution can contribute to allergic diseases and might also shed light on
the analogous events concerning the nitration of self-proteins.
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Introduction
In recent decades, studies have been addressing a possible
contribution of traffic related air pollution to allergic diseases [1–
6]. Interestingly, tyrosine residues of pollen allergens are efficiently
nitrated by the air pollutants nitrogen dioxide and ozone at levels
reached in urban air [7,8]. In sera of birch pollen-allergic patients,
the levels of IgE recognizing nitrated major birch pollen allergen
Bet v 1.0101 (referred to as Bet v 1 nitro) were significantly higher
compared to IgE specific for unmodified Bet v 1.0101 (Bet v 1) [6]
and in mouse models, nitrated Bet v 1 and nitrated Ovalbumin are
more potent allergens when compared to their unmodified forms
[6]. These findings suggest that post-translational modifications
(PTMs), such as nitration, can increase the potential of pollen
allergens to trigger immune responses and might play a role in the
emergence of allergies.
PTMs within the human body have been observed and
characterized in numerous studies. Although the majority of
PTMs are required for the biological function of the proteins,
several modifications were also identified in the context of
autoimmune diseases [9–11]. Nitrated proteins were found to be
present in multiple sclerosis [12,13], Alzheimer’s disease [14], M.
Parkinson [15,16] and atherosclerosis [17] and are a hallmark of
inflammation [18,19]. Some modified self proteins induce immune
responses leading to the generation of antibodies which recognize
the modified and/or the unmodified protein [6,20,21]. These
findings suggest that PTMs might alter processing and presenta-
tion of proteins by professional antigen presenting cells, leading to
the generation of new antigenic epitopes and potential induction of
a T cell response [19,22].
The presentation of protein fragments via HLA-DR molecules
by antigen presenting cells, such as mature dendritic cells (DCs), is
a key event in the induction of a T cell response [23,24]. After
internalization by dendritic cells, proteins are enzymatically
cleaved within endolysosomal compartments. Some of the
resulting peptides, which are of considerably variable length
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[25], bind to HLA-DR molecules in a sequence dependent and
HLA-DM-edited manner [26]. It has been established that PTMs
can increase the peptide binding affinity to MHC class II
molecules [27,28], or interfere with the proteolysis of proteins
[29]. This may, in addition to the alterations introduced by the
modified amino acid residue itself, result in the generation of new,
naturally processed HLA-DR associated peptides, potentially
giving rise to T cell epitopes [22]. For some PTMs, such as
maleylation [30–32] and nitration [33], there is evidence that
protein uptake by antigen presenting cells can be altered.
We have studied whether there is a difference between the
peptides derived from the allergen Bet v 1 presented via HLA-DR
and those derived from post-translationally chemically modified
Bet v 1 nitro. For this purpose, immature DCs were loaded with
unmodified Bet v 1 or Bet v 1 nitro. After affinity purification of
the HLA-DR peptide complexes, the HLA-DR associated
peptides were isolated by acidic elution and identified by liquid
chromatography-mass spectrometry and the identified Bet v 1 or
Bet v 1 nitro derived peptides were compared with respect to
peptide clusters, peptide length variants and copy number of
peptides.
Since changes in the pattern of presented HLA-DR associated
peptides on DCs can also change the recognition by T
lymphocytes, and since the conversion of tyrosine to nitrotyrosine
has already been shown to affect the reactivity of T cells for other
proteins [18,19], we also addressed the question whether
peripheral blood mononuclear cells (PBMCs) loaded with Bet v
1 nitro can activate T lymphocytes more efficiently than PBMCs
loaded with unmodified Bet v 1. For this purpose Bet v 1-specific T
cell lines were generated from birch pollen allergic patients and T
cell proliferation towards unmodified Bet v 1 or Bet v 1 nitro was
analyzed.
Results
Structural analysis and nitration of the allergen Bet v 1
and human serum albumin
The UCSF-Chimera [34] was used for the structural analysis of
the seven tyrosine residues of Bet v 1 (Figure 1A) regarding
accessibility and electrostatics on the protein databank entry
1BV1. With the exception of Y120, all tyrosine residues have
exposed 3-carbon atoms, indicating that they are available for
posttranslational modifications. Residues Y5, Y66, Y120, Y150
and Y158 are on the outside (Figure 1B), whereas Y81 and Y83
are exposed in the large cavity of Bet v 1 (Figure 1C). In terms of
accessibility, all tyrosine residues except Y120 are candidate
targets for nitration. In the X-ray structure, several water
molecules are found in the cavity, which indicates that there is a
reasonable space and polarity in the inside of the molecule. It has
been reported that one factor determining the selectivity of
nitration is the charge environment of the tyrosine resides [35].
The electrostatic potential was therefore calculated using DelPhi
[36] and mapped with the Chimera program to 1BV1. Most of the
targetable groups, with the exception of Y66, are in a negative
environment, which favours nitration. We subsequently applied
GPS-YNO2 [37], a recently developed predictor for potential
nitration sites based on sequence information. The predictor ranks
Y150 and Y158 with the highest scores, but also the inaccessible
Y120 with a high score. This data does not completely correspond
to the above mentioned structural analysis and suggests that the
prediction might not be fully optimized for Bet v 1.
Overall, the data suggest that Y5, Y81, Y83, 150 and 158 are
preferably nitrated, the latter two with a remarkable high score in
the GPS-YNO2 prediction. In contrast, Y66 is located in a positive
electrostatic environment and Y120 is not accessible and those two
residues are probably not nitrated to the same degree.
Treatment of Bet v 1 and human serum albumin (HSA) with
TNM led to nitration of tyrosine residues. We determined that
58.1% of all tyrosine groups within one protein molecule were
nitrated in both batches of Bet v 1 (data not shown). Donors B01
and B02 were loaded with nitro Bet v 1 of batch 1 and donors
B03–B10 were loaded with nitro Bet v 1 of batch 2. Two batches
of HSA nitro were generated with nitration grades of 21.4% and
26.3%.
Loading of DCs with unmodified Bet v 1 or Bet v 1 nitro
led to an alteration of the Bet v 1 derived peptide
repertoire presented via HLA-DR
Results of the peptides identified from DCs loaded with
unmodified Bet v 1 and Bet v 1 nitro are given in Figure 2. A
total of 1076 to 13367 peptides containing 381 to 1347 different
peptides were identified per sample generated from cells loaded
with Bet v 1, while Bet v 1 nitro derived samples gave rise to a total
of 758 to 14821 peptides containing 379 to 1380 different peptides
per sample. Despite this huge number of identified naturally
processed HLA-DR associated peptides some less frequent
peptides may not have been detected due to sensitivity limits of
the LC-ESI-MS/MS setup.
The majority of identified peptides were derived from a broad
panel of proteins present in the endolysosome. From this total
number of different identified peptides, an average of 0–0.8% of
the peptides were derived from Bet v 1 in samples generated from
DCs loaded with unmodified Bet v 1 and 0.3–7.2% of the total
peptides were derived from Bet v 1 nitro in samples generated
from DCs loaded with Bet v 1 nitro. Thus, the percentage of
different allergen-derived peptides related to the total number of
identified peptides in each sample was considerably increased in
samples generated from Bet v 1 nitro loaded DCs. All Bet v 1
derived peptides identified from different donors are listed in
supplementary table S2.
In none of the negative control samples, false positive Bet v 1-
derived peptides were identified, ruling out false positive
identification of allergen-derived peptides.
Allergen-derived peptides could be identified in samples
generated from DCs loaded with Bet v 1 or Bet v 1 nitro in
eight out of ten donors, or in all ten donors, respectively. Peptides
were derived from all regions of the Bet v 1 protein sequence,
except for region aa66–72 (Figure 2).
It is notable that the average length of Bet v 1 derived peptides
differed only marginally in samples generated from DCs loaded
with unmodified Bet v 1 (peptide length: 22.34 on average)
compared to Bet v 1 nitro (peptide length: 22.05 on average). The
sequences of naturally processed peptides found for Bet v 1
matched those identified by another study using DCs from 4
allergic patients [38].
Nitration increases the number of clusters as well as the
number of different length variants of Bet v 1-derived
naturally processed peptides
Identified peptides ‘‘clustered’’ in several regions along the
amino acid sequence (Figure 2). In peptide samples derived from
DCs loaded with unmodified Bet v 1, an average of 0.9 peptide
clusters per donor could be observed, while in samples derived
from Bet v 1 nitro loaded DCs, an average number of 2.6 peptide
clusters could be identified (Table 1). In region aa66–72,
containing a tyrosine residue, no allergen derived peptides could
be identified. In all other sequence regions containing tyrosine
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Figure 1. Structural analysis of the tyrosine residues in Bet v 1.0101. (A) Cartoon representation with alpha-helices in magenta and beta-
strands in yellow. The tyrosine residues are shown as sticks. (B) Electrostatic potential mapped to the protein surface. Positive charges are colored
blue and negative charges are colored red. The tyrosine residues are show as spheres, the CH groups are show in green color. (C) The front half of Bet
v 1 is cut off providing a view to the large central cavity. Tyrosines Y81 and Y83 are exposed to the cavity. The figure was prepared with UCSF Chimera
[34].
doi:10.1371/journal.pone.0031483.g001
Figure 2. Presentation of allergen derived naturally processed HLA-DR associated peptides by DCs from ten different donors (B01–
B10). Allergen derived peptides were detected in samples generated from unmodified Bet v 1 loaded DCs (light grey bars) and in samples generated
from Bet v 1 nitro loaded DCs (dark grey bars). In the sequence, tyrosine residues are highlighted grey.
doi:10.1371/journal.pone.0031483.g002
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residues, both, peptides with or without tyrosine modification
could be identified in samples generated from cells loaded with Bet
v 1 nitro. These peptides are listed in Supplementary Table S1 and
the data displayed in this table indicate that all tyrosine residues
were nitrated to some extent.
For all ten donors studied, peptide samples generated from Bet v
1 nitro loaded DCs showed a higher number of Bet v 1 derived
peptide length variants (with an average of 21.2 per donor)
compared to peptide samples isolated from DCs loaded with
unmodified Bet v 1 (with an average of 3 peptide length variants
per donor, Table 1). Nitration of Bet v 1 resulted in a 2.9-fold
increase in the number of identified Bet v 1 a-derived peptide
clusters and in a 7.2-fold increase in the number of identified
peptide length variants (i.e. 2.5-fold increase of peptide length
variant per cluster), resulting in a broader range of different
peptides being presented to T-lymphocytes.
Nitration of Bet v 1 increases the copy number of
identified Bet v 1-derived peptides
According to their amino acid composition, peptides with
different sequences exhibit different flight characteristics within
electrostatic and electrodynamic fields. Therefore, the detection
efficiency for different peptides can vary, which complicates a
quantitative comparison of the identified peptides in different
samples. Overall, 94.3%+/222.4 of the total peptides in samples
treated with Bet v 1 nitro was similar to the total number of
peptides in samples treated with unmodified Bet v 1. This implies a
similar peptide loading efficiency, recovery, and peptide distribu-
tion in samples generated from the same donor. Thus, within the
same donor it was eligible to compare quantities of peptides with
identical amino acid sequence and consequently identical flight
characteristics in the mass spectrometer within samples loaded
with unmodified Bet v 1 or Bet v 1 nitro. Therefore, peptides in
samples generated from DCs loaded with unmodified Bet v 1 were
compared with the identical peptides from samples generated from
DCs loaded with Bet v 1 nitro for each donor (Figure 3). Peptides
with the same sequence but containing nitrated tyrosine residues
were not taken into account, since the introduction of NO2 groups
might alter the flight characteristics of a peptide. Exemplarily for
two different peptide stretches aa133–157 in two different donors
B05 and B07 and aa102–132 in two different donors B06 and B08,
the top matched sequences are shown in the supplementary Table
S1.
Among 17 comparable sequences, we observed in all cases an
increase in the number of allergen derived peptides in samples
generated from DCs loaded with Bet v 1 nitro ranging from 1.1-
fold up to 106-fold in comparison to peptides in samples generated
from DCs loaded with unmodified Bet v 1. The mean increase in
peptides with identical sequences in DCs loaded with Bet v 1 nitro
compared to DCs loaded with unmodified Bet v 1 was 12.2 fold.
This indicates that nitration had a remarkable impact on the
presentation of allergen-derived peptides, and that DCs loaded
with Bet v 1 nitro accumulated a higher copy number of Bet v 1
derived HLA-DR peptide complexes Of note an increase in
allergen-derived peptides was not only observed in sequence
stretches containing tyrosine residues but also regions devoid of
tyrosine.
Nitration of Bet v 1 leads to an enhanced proliferation of
Bet v 1 specific T cell lines
In four out of five tested birch pollen allergic patient samples,
the proliferation of Bet v 1 specific T cell lines gave a higher
response to Bet v 1 nitro when compared to unmodified Bet v 1 at
the lowest tested concentration (1.25 mg/ml) (Figure 4). Statistical
analysis was performed for the lowest concentration for which the
difference in proliferation between Bet v 1 and Bet v 1 nitro was
the highest (1.25 mg/ml for donors 1, 2, 4, 5 and 2.5 mg/ml for
donor 3). With p= 0.046, proliferation of Bet v 1 specific T cell
lines in response to Bet v 1 nitro was significantly higher than
proliferation induced by unmodified Bet v 1. Proliferation of Bet v
1 specific T cell lines was very low upon control treatment with
HSA or HSA nitro, showing that the presence of nitrotyrosine as
such does not induce an increased T cell response. Interestingly,
increasing the Bet v 1 concentrations had little effect on the
proliferation and the difference between native and nitrated Bet v
1 was smaller and no longer significant.
HLA typing of donors
For donors B01–B10 used for isolation of HLA-DR associated
peptides from DCs, DRB1, DRB3, DRB4 and DRB5 alleles were
determined (Table 2). In general, peptide patterns of donors
sharing one allele also shared peptide clusters. Three out of four
donors with allele DRB1*0301 shared HLA-DR associated
peptides at aa1–48 and three out of three donors with allele
DRB1*1501 shared peptides at aa130–159. DRB1*0701 (present
in donors B02, B03 and B10) appears to be correlated with low
presentation of Bet v 1 peptides. Thus, in general, shared HLA-
DRB1 alleles correlated with the presentation of peptides derived
from the same region within Bet v 1. Interestingly, the effect of
nitration on the presentation of Bet v 1 peptides seems to be
independent of HLA alleles.
Discussion
Our study demonstrates that presentation of HLA-DR
associated peptides was altered upon nitration of Bet v 1. Nitration
resulted in a 2.9-fold increased number of identified peptide
clusters, a 7.2-fold increase in the overall number of peptide length
variants and a 12.2-fold increase in the copy number of identified
peptides derived from major birch pollen allergen. An increase in
allergen-derived peptide presentation was observed not only for
sequence stretches containing tyrosine residues but also in regions
devoid of tyrosine. This indicates a general change in uptake and/
or processing of the Bet v 1 nitro protein.
Table 1. Allergen derived peptide clusters and peptide
length variants identified in donors B01–B10.
Peptide clusters Peptide length variants
Donors Bet v 1 Bet v1 nitro Bet v 1 Bet v1 nitro
B01 1 3 1 23
B02 0 1 0 1
B03 1 2 2 4
B04 1 2 8 23
B05 1 2 7 31
B06 2 3 4 50
B07 1 4 4 20
B08 1 3 1 30
B09 1 3 3 27
B10 0 3 0 6
Average 0.9 2.6 3 21.5
doi:10.1371/journal.pone.0031483.t001
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There could be several explanations for the increase in the
presentation of Bet v 1 nitro derived peptides; 1) an enhanced
uptake of the allergen by the DCs, which could be due to
multimerization of the allergen. Consistently, for Bet v 1 nitro an
elevated tendency to form dimers and trimers was observed using
high performance size exclusion chromatography and Western
Figure 3. Nitration of Bet v 1 increases the copy number of identified allergen-derived peptides with identical amino acid
sequence. The numbers of detected copies of allergen derived peptides with identical peptide sequence, derived from DCs loaded with unmodified
Bet v 1 (grey bars) and allergen derived peptides derived from DCs loaded with Bet v 1 nitro (black bars) are shown for each identical peptide and
corresponding donors. Due to the limited amount of available cells for peptide isolation, each sample was measured only once.
doi:10.1371/journal.pone.0031483.g003
Figure 4. Bet v 1 specific T cell lines proliferate stronger in response to Bet v 1 nitro compared to unmodified Bet v 1 at 1.25 mg/ml
(p=0.046). Each symbol indicates the results of a single donor (n = 6) and the median is indicated with a horizontal bar. Treatment with 1.25 mg/ml
unmodified Bet v 1 or Bet v 1 nitro lead to a median proliferation value of 33293.5 delta cpm or 54157.0 delta cpm, respectively. Median proliferation
for treatment with 1.25 mg/ml HSA or HSA nitro could be determined as 336.3 delta cpm and 840.8 delta cpm respectively.
doi:10.1371/journal.pone.0031483.g004
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blot analysis (data not shown). 2) there are membrane bound
receptors recognizing nitrotyrosine; this would facilitate the uptake
of the nitrated allergen, and/or alter the processing of the allergen
within endolysosomal compartments of DCs. 3) nitration of
tyrosine residues has the potential to alter the sterical properties
and interaction with neighboring amino acids, resulting in changes
of the protein conformation and ultimately altered antigen
processing. 4) nitrotyrosine residues could render the allergen
either more or less susceptible to protease activity of degrading
enzymes without affecting the processing and presentation of
unmodified proteins [39]. A decrease in the stability of nitrated
allergens was confirmed in a recent study on food allergy. In this
study, the nitrated allergens administered orally in a mouse model
had a reduced allergenicity and were more easily digested. In
contrast, intravascular injection of nitrated food proteins did
increase their allergenicity [40]. Our data show that the average
length of allergen derived peptides differed only marginally
between samples from DCs loaded with unmodified allergen
(22.34 amino acids) or samples from DCs loaded with nitrated
allergen (22.98 amino acids). However, nitration could still affect
the kinetics of nitrated Bet v 1 degradation, consequently leading
to a change in the presentation kinetics of Bet v 1-derived peptides
and eventually the peptide profile which is presented to the T-cells.
Which of the delineated processes finally contributes to the increase
of Bet v 1 nitro derived peptide presentation remains unknown and the
interplay seems to be complex. Noteworthy, the nitration of human
serum albumin did not lead to an enhanced peptide presentation (data
not shown); suggesting that nitration per se does not result in enhanced
peptide presentation of the nitrated protein. Thus, the impact of
nitration on antigen presentation also seems to depend on the
properties of the protein itself. However, formally we cannot rule out
that the grade of nitration impacts on antigen presentation as well.
The identification of Bet v 1 derived HLA-DR associated
peptides led to the question, whether these peptides would be
recognized by T cell receptors of T lymphocytes and if this would
result in activation and proliferation of the T lymphocytes. For this
purpose PBMCs loaded with Bet v 1 nitro were assessed for their
capacity to stimulate Bet v 1 specific T cell lines. In response to Bet
v 1 nitro, proliferation was significantly higher as compared to
unmodified Bet v 1 using a concentration of 1.25 mg/ml protein.
Increasing the protein concentration did not in result in higher
proliferation and the impact of nitration was lower. Altogether,
our data showed that nitration not only enhanced presentation of
Bet v 1 derived HLA-DR associated peptides on DCs, but also had
an impact on T cell activation.
It has been hypothesized that nitration of autologous proteins
may contribute to autoimmunity [18]; additionally, the fact that
nitration occurs in inflamed tissue should be taken into account.
Nitration of tyrosine residues may have evolved as a strategy to
intensify immune responses against foreign proteins derived from
viruses or bacteria, while a possible contribution to autoimmunity
had to be accepted as an unfortunate side effect. Improved
presentation of pathogen derived nitrated peptides may in contrast
be beneficial to the host. Tyrosine nitration could also be seen as a
danger signal – a type of stimulus which is thought to play an
important role in the regulation of immune responses. Airborne
allergens bearing nitro-tyrosine mimic nitrated foreign proteins
present in inflamed tissue, which may explain our findings that
nitration of allergens intensifies the presentation of allergen
derived HLA-DR associated peptides. Previous studies have
shown increased immunogenicity of Bet v 1 nitro compared to
Bet v 1 [6]: Sera from patients with birch pollen allergy contain
higher titers for IgE against Bet v 1 nitro compared to Bet v1; the
reactivity against Bet v 1 nitro cannot be fully removed by
absorption with normal Bet v 1, indicating a specific recognition of
the nitrated allergen. The same study showed that nitrated Bet v 1
and nitrated Ovalbumin were more potent allergens compared to
their unmodified forms when tested in mouse models [6].
Regarding the issue of HLA haplotypes and the predisposition to
allergies published studies show diverging results. Several studies have
shown associations between IgE reactivity and the presence of distinct
HLA-DRB1 alleles; most notably in patients allergic to ragweed Amb
a 5, Alternaria Alt a 1, Parietaria Par o 1, birch Bet v 1, cat Fel d 1, as
well as cockroach and house dust mite allergens. In these cases HLA-
DRB1 haplotypes could favor susceptibility to allergy. However,
Jahn-Schmid et al. have recently shown that the dominant T cell
epitopes of the major ragweed allergen Amb a 1 were presented by
different HLA- DR, DP and DQ molecules [41]. These findings
suggest that, alternatively, a broad HLA class II restriction profile
might contribute to the high allergenic properties of Amb a 1.
Several questions remain to be addressed, e.g. if and/or how
nitrated proteins may interfere with uptake and/or processing
pathways of DCs or if potential alternative uptake mechanisms for
nitro-proteins e.g. via specialized receptors expressed on DCs
might exist. Furthermore, the questions whether chemical
nitration of the protein compared to nitration by NO2 and ozone
in polluted air have different characteristics (e.g. act on different
tyrosine residues) and whether they contribute to nitration to a
similar extent could not be investigated in the scope of the present
study. Environmental pollutants might nitrate tyrosine residues less
eagerly and more selectively than the chemical agent used here.
These aspects will have to be addressed in follow-up investigations.
In summary, our data show that nitration has an enhancing
effect on processing and presentation of Bet v 1 derived HLA-DR
associated peptides, by enhancing both the quality and the
quantity of the Bet v 1 specific peptide repertoire.
Materials and Methods
Allergen
Recombinant Bet v 1 isoform a (Bet v 1a/Bet v 1.0101) was
purchased from Biomay, Vienna.
HLA-DR-specific antibody
The hybridoma cell line L243 [42] was used for the production
of monoclonal antibodies specific for HLA-DRab dimers. HLA-
Table 2. HLA-DRB-alleles of the donors B01 to B10.
Allele
Donor DRB1 DRB1 DRB3 DRB3 DRB4 DRB4 DRB5 DRB5
B01 1104 1301 0101 0202
B02 0426 0701 0103
B03 0301 0701 0202 0101
B04 0301 1501 0101 0101
B05 0101 1501 0101
B06 0301 1101 0101 0202
B07# 1201 1501
B08 0301 1101 0101 0202
B09 0404 1101 0202 0103
B10 0701 1302 0301 0103
#For donor B 07 only the DRB1 alleles were determined.
doi:10.1371/journal.pone.0031483.t002
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DR specific antibodies were purified from hybridoma supernatants
by Protein A chromatography, immobilized on CNBr-activated
sepharose beads (Pharmacia) according to the manufacturer’s
protocol and stored containing 0.02% sodium azide.
Nitration of major birch pollen allergen
Recombinant Bet v 1 was dissolved in H2O at a concentration
of 1 mg/ml. Protein concentration was determined using a Bio-
Rad Protein assay (Bio-Rad, Munich, Germany). Nitration of the
allergen was performed with an excess of 30 tetranitromethane
(TNM) molecules per tyrosine residue. To generate Bet v 1 nitro,
half of the allergen solution was mixed with 0.5 M TNM/
methanol solution (Chemos, Regenstauf, Germany) to a final
concentration of 12.03 mM TNM. The other half of the allergen
solution was mixed with the corresponding amount of methanol
without TNM, to generate unmodified Bet v 1. After incubation
for 60 min at room temperature, the protein solutions were
purified by size exclusion chromatography using PD-10 Sephadex
G-25M columns (GE Healthcare, Uppsala, Sweden), in order to
remove potential smaller protein fragments generated during the
chemical modification. The protein concentrations were deter-
mined using the Bio-Rad Protein assay and the nitration grade was
determined based on a standard curve using nitrotyrosine by
measurement of the samples at 420 nm [40].
Generation of monocyte derived DCs
DCs were generated from peripheral blood mononuclear cells
(PBMCs). PBMCs were purified from buffy coats obtained from
healthy donors from the blood bank in Basel using Ficoll gradient
centrifugation. Monocytes were purified from peripheral blood
mononuclear cells by positive selection using CD14-specific
antibody coated MicroBeads (Miltenyi Biotech, Auburn, CA)
and differentiated to immature DCs in complete RPMI supple-
mented with granulocyte macrophage-colony stimulating factor
(GM-CSF, 33 ng/ml) and interleukin-4 (IL-4, 3 ng/ml) for 5 days
at 37uC and 5% CO2. DCs were shown to be in the immature
state, as characterized by very low expression of CD86 and lack of
expression of CD83.
Loading of DCs with allergens
Maturation of the immature DCs was induced after five days
with LPS (1 mg/ml, Sigma, St. Louis, MO). The DCs were either
loaded with 10 mg/ml unmodified Bet v 1 or Bet v 1 nitro.
Unloaded DCs served as background control. After 24 hours, DCs
were harvested after re-suspension and washing in PBS. The cell
pellets were immediately frozen at 270uC.
Isolation of HLA-DR restricted peptides
DC pellets (obtained from 16107 cells) were lyzed in hypotonic
buffer containing 1% Triton X-100 and protease inhibitors for
1 hour on a horizontal shaker. The lysate was cleared from cell
debris and immunoprecipitated with mAb L243 conjugated
sepharose beads. After washing with double-distilled water, elution
of peptides from HLA-DR molecules was achieved with 0.1%
trifluoracetic acid (Fluka, Buchs, Switzerland) at 37uC. The
peptides were lyophilized in an Eppendorf Concentrator 5301
(Eppendorf AG, Hamburg, Germany). Cell lysates, before and
after immunoprecipitation, were analyzed by Western Blotting
using the HLA-DRa-specific mAb 1B5 to determine the HLA-DR
depletion efficacy.
Mass spectrometry
Peptide identification was performed using multidimensional
protein identification technology (MudPIT) combining a two
dimensional liquid chromatography with a mass spectrometric
analysis (LC-ESI-MS/MS). Lyophilized peptides were resus-
pended in hydrophilic buffer containing 5% acetonitrile, 0.5%
acetic acid, 0.012% heptafluorbutyric acid and 1% formic acid.
Peptides were fractionated using a MudPIT column packed with
C18 reversed phase material and SCX material. Elution of the
peptides from the column was performed in 10 cycles on an
UltiMate 3000 nanoflow HPLC (Dionex Corporation, Sunnyvale,
CA). The first six cycles started with a salt step with increasing
concentrations of ammonium acetate (0–225 mM) followed by a
nonlinear acetonitrile gradient. The seventh cycle consisted of a
salt step with 250 mM ammonium acetate and a nonlinear
acetonitrile gradient. The last three cycles started with a salt step
with 1500 mM ammonium acetate followed by a nonlinear
acetonitrile gradient. The MudPIT column was coupled to a
LTQ/Orbitrap ion trap mass spectrometer (Finnigan, San Jose,
CA). Peptide identification was performed using the SEQUEST
Algorithm. For database searches, the sequence of the allergen Bet
v 1 was included in a Swiss-Prot deduced database. Peptides were
evaluated according to their quality requirements based on the
sequence variables cross correlation (Xcorr) and delta cross-
correlation (dCn). Only peptides with a dCn .0.1 and a cross
correlation of Xcorr .1.8 for singly charged ions, Xcorr .2.3 for
doubly charged ions and Xcorr .2.8 for triply charged ions were
considered. Due to limited amount of available cells and thus
limited amounts of sample, multiple injections were not feasible.
Therefore each sample could only be measured once. Neverthe-
less, most of the Bet v 1-derived peptides were detected several
times during one run, each resulting in a separate mass spectrum.
In addition, within one sequence clusters usually several length
variants were identified and most of the presented peptide clusters
were present in several donors with the same HLA-types. This
confirmed the identity of the presented peptide stretches. As a
negative control and to rule out false positive identification of Bet v
1-derived peptides, cell-derived peptides from mature unloaded
DCs were used.
Determination of HLA-DRB alleles
Low resolution determination of the HLA-DRB1 tissue type
was performed for each blood donor using a commercial SSO
typing kit (DynalRELI SSO HLA-DRB Typing kit, Invitrogen,
Bromborrough, UK). Low resolution analysis of the HLA-DRB3/
4/5 tissue type was performed using a ligation based typing
approach [43]. High resolution analysis of HLA-DRB1 and HLA-
DRB3/4/5 tissue types was performed by nucleotide sequencing
of exon 2 (BigDye Terminator Cycle Sequencing Kit, ABI, Foster
City, CA). In addition, for high resolution typing of DRB4 alleles,
a commercial SSP kit was used (Olerup SSPTM DRB4, Qiagen,
Hilden, Germany).
Patient selection
All birch pollen-allergic patients had a typical case history,
specific IgE RAST/CAP class .3 to Bet v 1 (Pharmacia
Diagnostics, Uppsala, Sweden), and positive skin prick reactions
(wheal diameter .5 mm) to Bet v 1. All patients gave written
consent before enrolment in the study, which was approved by the
Ethics Committee of the Medical University of Vienna.
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Allergen-specific T cell lines (TCL)
PBMC were isolated from the blood of birch pollen allergic
donors by Ficoll-Hypaque density gradient centrifugation. For the
generation of allergen-specific T cells, 1.56106 PBMCs were
stimulated with 10 mg/ml unmodified Bet v 1 or Bet v 1 nitro in
24-well flat-bottom culture plates (Costar, Cambridge, MA). On
day 5, 10 U/ml human IL-2 (Boehringer Mannheim, Mannheim,
Germany) were added. On day 7, T cell blasts were enriched by
density gradient centrifugation and cultures were expanded at
weekly intervals with irradiated PBMCs and IL-2. Before the
experiment, T cells were rested for 10 to 14 days. To test allergen
specificity, the T-cell lines (TCL) were stimulated in the presence
of 56104 irradiated autologous PBMCs for 48 h in duplicate with
varying concentrations of unmodified Bet v 1 (1.25 mg/ml, 2.5 mg/
ml, 5 mg/ml) and equimolar amounts of Bet v 1 nitro, respectively.
After a 16 h pulse with 0.5 mCi of [3H]TdR (GE Healthcare,
Munich, Germany), cultures were harvested and radionuclide
uptake was measured by scintillation counting. The stimulation
index (SI) was calculated as ratio between counts per minute (cpm)
of TCL, PBMCs and antigen, and cpm of TCL and PBMCs only.
Delta cpm (dpm) were calculated as cpm of TCL plus PBMCs plus
protein minus cpm of TCL and PBMC only. TCL were
considered as specific when the SI was .2.5.
Statistical analysis
T-cell proliferation data were analyzed by Wilcoxon Signed
Ranks Test using the software package SPSS (SPSS Inc., Chicago,
IL, USA).
Supporting Information
Table S1 Top scored Bet v 1-derived peptides of donors B5–B8.
Nitrated Tyrosine residues are indicated as Y,. Oxidized
methionine residues occuring during sample storage are indicated
as M*.
(DOC)
Table S2 List of all identified Bet v 1-derived peptides. Listed
are all identified Bet v 1-derived peptides in samples treated with
unmodified Bet v 1 or Bet v 1 nitro for each donor. For samples
treated with Bet v 1 nitro, copy numbers of peptides identified
containing unmodified (Y) or nitrated tyrosine (Y*) are listed in
separate columns. Peptide sequences are arranged according to
the position of the first amino acid within the protein sequence.
(XLS)
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